enow.com Web Search

  1. Ads

    related to: diseases caused by hepatitis c treatment new drugs

Search results

  1. Results from the WOW.Com Content Network
  2. Hepatitis C - Wikipedia

    en.wikipedia.org/wiki/Hepatitis_C

    Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; [2] it is a type of viral hepatitis. [6] During the initial infection period, people often have mild or no symptoms. [1] Early symptoms can include fever, dark urine, abdominal pain, and yellow tinged skin. [1]

  3. What People Who Inject Drugs Should Know about Hepatitis C ...

    www.aol.com/lifestyle/people-inject-drugs-know...

    Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Experts estimate that about 2.4 million people in the United States are living with hepatitis C—but that figure ...

  4. Here's What Hepatitis C Actually Is—and How You Get It - AOL

    www.aol.com/lifestyle/heres-hepatitis-c-actually...

    The causes of the diseases are quite different: AIH may have a genetic component, according to the National Institute of Diabetes and Digestive and Kidney Diseases; meanwhile, hepatitis C is ...

  5. Understanding hepatitis C: A growing public health concern - AOL

    www.aol.com/news/understanding-hepatitis-c...

    Mar. 14—Hepatitis C is a liver infection caused by the hepatitis C virus. It is becoming a big public health concern in many counties, including Lawrence County, encouraging us to review some ...

  6. Sofosbuvir/velpatasvir - Wikipedia

    en.wikipedia.org/wiki/Sofosbuvir/velpatasvir

    Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. [2] [5] [6] [7] It combines sofosbuvir and velpatasvir. [2] [5] [6] It is more than 90% effective for hepatitis C genotypes one through six. [2]

  7. Glecaprevir - Wikipedia

    en.wikipedia.org/wiki/Glecaprevir

    Glecaprevir (INN, [1]) is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor that was identified jointly by AbbVie and Enanta Pharmaceuticals. [2] It is being developed as a treatment of chronic hepatitis C infection in co-formulation with an HCV NS5A inhibitor pibrentasvir.

  1. Ads

    related to: diseases caused by hepatitis c treatment new drugs